Gestational Trophoblastic Disease
John R. Lurain, Michael J. Seckl, Julian C. Schink
Abstract
John R. Lurain, Michael J. Seckl, Julian C. Schink
Abstract
Gestational trophoblastic disease is a spectrum of interrelated abnormal proliferations of the placental trophoblast, encompassing benign hydatidiform moles (complete and partial) as well as gestational trophoblastic neoplasia, which includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and its related epithelioid trophoblastic tumor. Early detection of hydatidiform moles with ultrasonography and advances in uterine evacuation techniques have decreased serious bleeding and medical complications of molar pregnancy. The availability of accurate tests for measuring human chorionic gonadotropin as a disease-specific tumor marker and the introduction of chemotherapy into the management of gestational trophoblastic neoplasia have significantly reduced deaths so that the overall cure rate in treating these tumors is greater than 90% even in the presence of widely metastatic disease.
OpenAlex reports 44 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gestational trophoblastic disease is a spectrum of interrelated abnormal proliferations of the placental trophoblast, encompassing benign hydatidiform moles (complete and partial) as well as gestational trophoblastic neoplasia, which includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and its related epithelioid trophoblastic tumor. Early detection of hydatidiform moles with ultrasonography and advances in uterine evacuation techniques have decreased serious bleeding and medical complications of molar pregnancy. The availability of accurate tests for measuring human chorionic gonadotropin as a disease-specific tumor marker and the introduction of chemotherapy into the management of gestational trophoblastic neoplasia have significantly reduced deaths so that the overall cure rate in treating these tumors is greater than 90% even in the presence of widely metastatic disease.
Key concepts: Placental site trophoblastic tumor, Partial Hydatidiform Mole, Choriocarcinoma, Gestational trophoblastic disease, Trophoblastic Tumor, Molar pregnancy, Gestational trophoblastic neoplasia, Human chorionic gonadotropin